Treatment Clinical Trial
Official title:
Cardiovascular Conditioning in the Treatment of Vocal Fatigue
Verified date | November 2023 |
Source | East Tennessee State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Teachers are a population at high risk for voice disorders given their occupational demands. In a teaching career, a common debilitating symptom among all vocal symptoms experienced is - vocal fatigue, impacting teachers' occupational performance and increasing health care costs. It is therefore essential to identify potential treatment options to alleviate the symptom of vocal fatigue. The purpose of this study is to utilize a body-system level cardiovascular training protocol in comparison to traditional voice production training to alleviate the symptoms of vocal fatigue.
Status | Completed |
Enrollment | 31 |
Est. completion date | June 6, 2023 |
Est. primary completion date | March 30, 2023 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 21 Years to 60 Years |
Eligibility | Inclusion Criteria: - Female teachers between the ages of 21-60 years Female instructors and college professors between the ages of 21-60 years - A score of = 15 on factor 1 of the VFI (tiredness and avoidance of voice use) or a score of = 5 on factor 3 of the VFI (improvement of symptoms or lack thereof with rest) - Sedentary- wherein participants will need to be completing mild intensity cardiovascular exercise less than 150 minutes in less than 5 days per week Exclusion Criteria: - Trained athletes - Trained singers - Smoking in the past 6months - Prior history of a vocal fold pathology and current vocal fold pathology |
Country | Name | City | State |
---|---|---|---|
United States | East Tennessee State University | Johnson City | Tennessee |
Lead Sponsor | Collaborator |
---|---|
East Tennessee State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in Physiologic Cost of Speaking | Physiologic Cost of Speaking is measured as the rate of oxygen consumption at steady state/ rate of speech (wpm) for each of the two reading tasks | At baseline, at 4 weeks after treatment | |
Primary | Changes in Oxygen Uptake Kinetics | Oxygen Uptake Kinetics is measured as the pattern of oxygen use during each of the two reading tasks | At baseline, at 4 weeks after treatment | |
Primary | Changes in Post Task Physiological Recovery | Post Task Physiological Recovery is measured as the time, seconds, to reach baseline of oxygen consumption post task (within 0.2ml/kg/min) following each of the reading tasks | At baseline, at 4 weeks after treatment | |
Primary | Changes in Excess Post Exercise Consumption (EPOC) | EPOC is measured as the magnitude of recovery oxygen consumption, ml/kg/min for each of the reading tasks | At baseline, at 4 weeks after treatment | |
Primary | Changes in Ratings of Perceived Exertion (RPE) | Borg Scale of Ratings of Perceived Exertion (RPE)- measures the self-report of vocal effort for each of the reading tasks | At baseline, at 4 weeks after treatment | |
Primary | Changes in Vocal Fatigue Index (VFI) | Vocal Fatigue Index (VFI) is a retrospective scale that measures self-reported symptoms of vocal fatigue | At baseline, at 4 weeks after treatment | |
Primary | Changes in Global Rating of Vocal Fatigue (VAS 100mm) | Global Rating of Vocal Fatigue (VAS 100mm) measures the ability to sustain voice with no fatigue at the end of a working day | At baseline, at 4 weeks after treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05243134 -
The Influence of Anatomic Deformities on the Clinical Efficacy in the Patients With Patellar Dislocation
|
||
Completed |
NCT02486874 -
Clinical Evaluation of PoreSkin
|
Phase 1 | |
Active, not recruiting |
NCT04592640 -
Stem Cells for Uremic Calciphylaxis Patients
|
N/A | |
Recruiting |
NCT04599686 -
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate Cancer
|
N/A | |
Recruiting |
NCT03351842 -
Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%
|
Phase 2 | |
Completed |
NCT02782442 -
Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)
|
N/A | |
Completed |
NCT03439930 -
The Effect of Balance Training on Neuromuscular Control in Subjects With CAI
|
N/A | |
Not yet recruiting |
NCT05537155 -
Buccal Acupuncture for Delirium Treatment in Older Patients Recovering From Orthopedic Surgery
|
N/A | |
Recruiting |
NCT02971982 -
PCD Versus RCD for the Treatment of Patients With Waldenstrom's Macroglobulinemia
|
Phase 1/Phase 2 | |
Completed |
NCT02820272 -
Water for Reducing Pain in Negative Pressure Wound Therapy
|
Phase 2 | |
Completed |
NCT00984958 -
Bulkamid Treatment of Stress Incontinence in Women With Urinary Stress Incontinence and Not Suitable to TVT-procedure
|
N/A | |
Completed |
NCT00575224 -
Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9
|
Phase 4 | |
Completed |
NCT00164528 -
Intervening With Children/Adolescents With FAS/ARND
|
Phase 1/Phase 2 | |
Completed |
NCT00164307 -
Assisting Children With Prenatal Alcohol Exposure in Developing Peer Friendships
|
Phase 1/Phase 2 | |
Recruiting |
NCT04603586 -
Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses
|
N/A | |
Recruiting |
NCT03375424 -
Vedolizumab Study With Inflammatory Bowel Disease Patients in Germany
|
N/A | |
Not yet recruiting |
NCT04062370 -
Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion
|
Phase 4 | |
Not yet recruiting |
NCT02931136 -
Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging
|
Phase 4 | |
Completed |
NCT04661228 -
Diagnostic Survey of Mental and Substance Use Disorders in HUNT (PsykHUNT)
|
||
Recruiting |
NCT03365141 -
Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo
|
N/A |